Liliya Mikhailovna Buraya

Mrs. Liliya Mikhailovna Buraya


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2024 in Gels
Verified
Journal Article
Open access
PDF file
EBElena Bakhrushina
Elena Bakhrushina
IMIosif B. Mikhel
Iosif B. Mikhel
LBLiliya Mikhailovna Buraya
Liliya Mikhailovna Buraya
EMEgor D. Moiseev
Egor D. Moiseev
IZIrina M. Zubareva
Irina M. Zubareva
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
Implantation is a modern method of administering chemotherapeutic agents, with a highly targeted effect and better patient tolerance due to the low frequency of administration. Implants are capable of controlled release, which makes them a viable alternative to infusional chemotherapy, allowing patients to enjoy a better quality of life without the need for prolonged hospitalization. Compared to subcutaneous implantation, intratumoral implantation has a number of significant advantages in terms of targeting and side effects, but this area of chemotherapy is still poorly understood in terms of clinical trials. At the same time, there are more known developments of drugs in the form of implants and injections for intratumoral administration. The disadvantages of classical intratumoral implants are the need for surgical intervention to install the system and the increased risk of tumor rupture noted by some specialists. The new generation of implants are in situ implants—systems formed in the tumor due to a phase transition (sol–gel transition) under the influence of various stimuli. Among this systems some are highly selective for a certain type of malignant neoplasm. Such systems are injected and have all the advantages of intratumoral injections, but due to the phase transition occurring in situ, they form depot forms that allow the long-term release of chemotherapeutic agents.

25 March 2023 in Sciences of Pharmacy
Verified
Journal Article
Open access
PDF file
EBElena Bakhrushina
Elena Bakhrushina
LBLiliya Mikhailovna Buraya
Liliya Mikhailovna Buraya
EMEgor D Moiseev
Egor D Moiseev
MSMarina M. Shumkova
Marina M. Shumkova
MDMaria Davydova
Maria Davydova
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
Abiraterone acetate is one of the effective therapies in castration-resistant prostate cancer. There is only one dosage form in the form of film-coated tablets. Abiraterone has proven effective but has disadvantages and contraindications that complicate therapy. One of them is a positive food effect affecting the bioavailability and side effects of the drug. Abiraterone is taken strictly on an empty stomach, and the bioavailability of the drug, in this case, reaches only 10%. In addition, the drug is contraindicated in people with hepatic insufficiency since the main metabolism is in the liver. These and other disadvantages can be eliminated by obtaining targeted delivery systems - liposomes and nanocrystals. Another dosage form could be considered for the active pharmaceutical agent that would be cost-effective, accessible and have higher bioavailability for effective treatment. An intratumoral polymeric in situ implant is chosen as an excellent dosage form, the matrix of which will contain an optimized form of abiraterone, which can stably target a tumor.

Verified
Journal Article
Open access
PDF file
Hadi Majed Soud DarawshehHadi Majed Soud Darawsheh
Hadi Majed Soud Darawsheh
MSMarina M. Shumkova
Marina M. Shumkova
LBLiliya Mikhailovna Buraya
Liliya Mikhailovna Buraya
MPMaria Pomytkina
Maria Pomytkina
GPGhazaleh Pouya
Ghazaleh Pouya
YVYuriy Vasil'ev
Yuriy Vasil'ev
Alveolitis remains a common postoperative complication following tooth extraction, characterized by inflammation and delayed socket healing. Collagen-based materials have shown promise in promoting tissue regeneration and reducing inflammation. This review evaluates the efficacy of collagen in the prevention of alveolitis, with a focus on the development and application of topical delivery systems such as gels and collagen sponges. Special attention is given to the local application of these systems within the extraction socket and their performance under oral conditions. The study analyzes current evidence on the pathogenesis of alveolitis, the biological properties of collagen relevant to wound healing, and pharmaceutical strategies for enhancing its clinical effectiveness. The findings support the feasibility of using biodegradable, site-specific collagen-based formulations for alveolitis prevention. Such systems may provide a prolonged therapeutic effect, stabilize blood clots, reduce microbial contamination, and support angiogenesis and osteogenesis throughout the healing process. This approach offers a promising direction for improving post-extraction management protocols in dental surgery.